HomeALT • NASDAQ
Altimmune Inc
add
$5.43
3.21%
Pre-market:(1.66%)+0.090
$5.52
Closed: Jun 2, 6:40:27 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 5.00K | 0.00% |
Operating expense | 5.99M | 12.82% |
Net income | -19.58M | 19.75% |
Net profit margin | -391.50K | 19.75% |
Earnings per share | -0.26 | 23.53% |
EBITDA | -21.79M | 18.36% |
Effective tax rate | 3.36% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 149.83M | -17.69% |
Total assets | 157.26M | -16.51% |
Total liabilities | 15.10M | -2.08% |
Total equity | 142.16M | — |
Shares outstanding | 81.11M | — |
Price to book | 3.07 | — |
Return on assets | -36.78% | — |
Return on capital | -40.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -19.58M | 19.75% |
Cash from operations | -16.84M | -2.95% |
Cash from investing | -5.10M | 87.09% |
Cash from financing | 34.12M | 13,172.41% |
Net change in cash | 12.18M | 121.69% |
Free cash flow | -10.30M | -37.48% |
Previous close
$5.61
Day range
$5.35 - $5.59
Year range
$3.56 - $11.16
Market cap
440.41M USD
Avg Volume
2.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1997
Headquarters
Website
Employees
59
